Moderna says US government on the hook to pay any royalties due to mRNA patent owners
The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law
The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law
Bob Giles, top IP lawyer for the San Diego chip innovator, also says standards-setting process works well, downplaying concerns that it is being gamed
Major companies must now figure out how to maintain compliance with the new measures in IP and other areas
The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits
06 January 2022
Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.
05 January 2022
Latest patent deals related to the next-gen wireless internet standard suggest patent owners spy monetisation opportunities
04 January 2022
Predictions from the IAM editorial team on what the next twelve months have in store
03 January 2022
Kathi Vidal, Ericsson, Arthrex and Judge Alan Albright were among the names that made the IP headlines over the course of the year
23 December 2021
New German legislation, a leap forward on the UPC and important SEP-related initiatives from the UK and the Commission were among the highlights of a busy year
23 December 2021
Landscape analysis reveals a space where automakers, suppliers and tech companies are all active and portfolio strategies are largely focused on one or two jurisdictions
22 December 2021
From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries
21 December 2021
Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses
21 December 2021
A wide-ranging overhaul of the law, big moves on FRAND and a major departure were among the highlights of a busy year
20 December 2021
Get unlimited access to all IAM content